Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
Notice NOT-NS-18-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 12, 2018 Category: Research Source Type: funding

Division of Chemistry: Disciplinary Research Programs (CHE-DRP)
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18561/nsf18561.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18561/nsf18561.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18561This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - June 7, 2018 Category: Science Source Type: funding

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-820 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic therapeutic agents that prevent Alzheimer's disease (AD), slow its progression or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry, pharmacokinetics (PK), Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET), efficacy in animal models, fo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 7, 2018 Category: Research Source Type: funding

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
Funding Opportunity PA-18-818 from the NIH Guide for Grants and Contracts. The reproducibility and comparability of research on dietary supplements is enhanced by rigorous analytical characterization of key experimental materials and the publication of validated analytical methods that accurately and precisely characterized and quantify constituents in dietary supplement ingredients and products. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods. The methods proposed for validation must be used to identify and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 5, 2018 Category: Research Source Type: funding

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
The reproducibility and comparability of research on dietary supplements is enhanced by rigorous analytical characterization of key experimental materials and the publication of validated analytical methods that accurately and precisely characterized and quantify constituents in dietary supplement ingredients and products. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods. The methods proposed for validation must be used to identify and quantify dietary supplement-relevant chemical constituents (i.e., active or...
Source: NIDDK Funding Opportunities - June 5, 2018 Category: Endocrinology Source Type: funding

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-18-814 from the NIH Guide for Grants and Contracts. The NINDS, with other NIH Institutes and Centers participating in the BRAIN Initiative, intends to publish "BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00)." The program is designed to increase biomedical research workforce diversity and foster a strong cohort of new, highly skilled and well trained, NIH-supported, independent investigators from underrepresented groups working in research areas supported by the BRAIN Initiative, as highlighted in BRAIN 2025: A Scientific Vision. It is designe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 1, 2018 Category: Research Source Type: funding

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-19-136 from the NIH Guide for Grants and Contracts. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new ge...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 3, 2018 Category: Research Source Type: funding

Dear Colleague Letter: Data-Driven Discovery Science in Chemistry (D3SC)
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18075/nsf18075.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18075/nsf18075.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18075This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - May 1, 2018 Category: Science Source Type: funding

Dear Colleague Letter: Special Guidelines for Submitting Collaborative Proposals under the Division of Chemical, Bioengineering, Environmental, and Transport Systems, the Division of Civil, Mechanical and Manufacturing Innovation, and the Division of Electrical, Communications and Cyber Systems - the UK Engineering and Physical Sciences Research Council (ENG-EPSRC) Lead Agency Activity
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18067/nsf18067.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18067/nsf18067.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18067This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - April 19, 2018 Category: Science Source Type: funding

Centers for Chemical Innovation (CCI) Phase I Awards and Phase II Center Renewal
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18555/nsf18555.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18555/nsf18555.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18555This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - April 17, 2018 Category: Science Source Type: funding

Notice of Participation in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)
Notice NOT-NS-18-053 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 29, 2018 Category: Research Source Type: funding

Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-721 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) exploratory/developmental translational research (R21). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics to mitigate the health effects of chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2018 Category: Research Source Type: funding

Dear Colleague Letter: Improving Graduate Student Preparedness for the Chemistry Workforce
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18056/nsf18056.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18056/nsf18056.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18056This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - March 21, 2018 Category: Science Source Type: funding

BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-18-020 from the NIH Guide for Grants and Contracts. Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for largescale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. In particular, we seek exceptionally creative approaches to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2018 Category: Research Source Type: funding

BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-18-019 from the NIH Guide for Grants and Contracts. Although invention and proof-of-concept testing of new technologies are a key component of the BRAIN Initiative, to achieve their potential these technologies must also be optimized through feedback from end-users in the context of the intended experimental use. This seeks applications for the optimization of existing and emerging technologies and approaches that have potential to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and temporal scales, in any r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2018 Category: Research Source Type: funding

Dear Colleague Letter: Enabling Quantum Leap in Chemistry (QLC)
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18051/nsf18051.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18051/nsf18051.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18051This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - March 8, 2018 Category: Science Source Type: funding

BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Funding Opportunity RFA-EY-18-001 from the NIH Guide for Grants and Contracts. A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some understanding, they may not be sufficient to accomplish this goal. For example, non-invasive technologies are low resolution and/or provide indirect measures such as blood flow, which are imprecise; invasive technologies can provide information at the level of single neurons producing the fundamental bio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 2, 2018 Category: Research Source Type: funding

Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
Funding Opportunity RFA-NS-18-025 from the NIH Guide for Grants and Contracts. This funding opportunity announcement(FOA) supports the development of PET radioligands that identify proteinopathies or pathological processes associated with the human biology of Alzheimer's disease related dementias (ADRDs). Activities supported under this FOA include, but are not limited to the in vitro screening of existing ligands against human ADRD brain tissue, medicinal chemistry support for improvement of ligand specificity and selectivity, initial screening of ligands in appropriated animal models, and radioligand formulation and fir...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 2, 2018 Category: Research Source Type: funding

Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PA-18-682 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 26, 2018 Category: Research Source Type: funding

Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
Funding Opportunity PAR-18-657 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2018 Category: Research Source Type: funding

NSF/CASIS Collaboration on Fluid Dynamics and Particulate and Multiphase Processes Research on the International Space Station to Benefit Life on Earth
Full Proposal Window: March 5, 2018 Program Guidelines: NSF 18-521The Division of Chemical, Bioengineering and Environmental Transport (CBET) in the Engineering Directorate of the National Science Foundation (NSF) is partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general field of fluid dynamics and particulate and multiphase processes that can utilize the International Space Station (ISS) National Lab to conduct research that will benefit life on Earth. U.S. entities including academic ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505258&WT.m...
Source: NSF Upcoming Due Dates - February 3, 2018 Category: Science Source Type: funding

Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PA-18-607 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research SBIR grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding

Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-608 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address highly innovative methods and technologies that significantly advance the field of natural products. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2018 Category: Research Source Type: funding

NSF/CASIS Collaboration on Tissue Engineering on the International Space Station to Benefit Life on Earth
Full Proposal Window: February 12, 2018 Program Guidelines: NSF 18-514The Division of Chemical, Bioengineering and Environmental Transport (CBET) in the Engineering Directorate of the National Science Foundation (NSF) is partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general field of tissue engineering that can utilize the International Space Station (ISS) National Lab to conduct research that will benefit life on Earth. U.S. entities including academic institutions, non-profit independent ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505490&...
Source: NSF Upcoming Due Dates - January 13, 2018 Category: Science Source Type: funding

Dear Colleague Letter: Division of Chemistry's 2018 Supplemental Funding Requests for International Collaboration
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18037/nsf18037.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18037/nsf18037.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18037This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - January 5, 2018 Category: Science Source Type: funding

Two Years (or so) of “Open Mike”
Last year, as I reflected on finishing my first full year as NIH Deputy Director for Extramural Research, I noted five themes that reflected most of the content of this blog: applicant behavior, activity, and outcomes; peer review; basic science; biomedical research workforce and training; and scientific rigor, transparency, and research impact. Looking back on 2017, which was certainly a busy and active year, many of these themes continue to be at the forefront, though one in particular, the make-up and future of the biomedical research workforce, has been the center of much debate. On May 2, we posted a blog on “Im...
Source: NIH Extramural Nexus - December 29, 2017 Category: Research Authors: Mike Lauer Tags: blog Open Mike General Source Type: funding

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
Funding Opportunity PAR-18-541 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) encourages applications from small businesses seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2017 Category: Research Source Type: funding

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
Funding Opportunity PAR-18-546 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2017 Category: Research Source Type: funding

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
Funding Opportunity RFA-DA-19-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose. The UG3/UH3 Phase Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed the milestones set in the UG3. UG3 projects that have met their milestones will be administratively conside...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2017 Category: Research Source Type: funding

NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)
Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop mod...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2017 Category: Research Source Type: funding

Notice of Interest to Highlight NIDA High-Priority Workforce Development Needs in the Chemistry of Addiction
Notice NOT-DA-17-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2017 Category: Research Source Type: funding

Countermeasures Against Chemical Threats (CounterACT): Opportunities in Opioid Research
Notice NOT-NS-18-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2017 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
Funding Opportunity PA-18-396 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2017 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Clinical Trial Required)
Funding Opportunity PA-18-395 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2017 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Clinical Trial Required)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. (Source...
Source: NIDDK Funding Opportunities - November 22, 2017 Category: Endocrinology Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. (Source...
Source: NIDDK Funding Opportunities - November 22, 2017 Category: Endocrinology Source Type: funding

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Funding Opportunity PAR-18-174 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development ofsmall-molecule and biologic therapeutic agents that prevent Alzheimer's disease (AD), slow its progression or treat its cognitive and behavioral symptoms.Participants in this program will receive funding for therapy development activities such as medicinal chemistry, pharmacokinetics (PK), Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET), efficacy in animal models, formulatio...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2017 Category: Research Source Type: funding

Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21 Clinical Trial Optional)
Funding Opportunity PA-18-160 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases; including lower respiratory disease, chronic obstructive pulmonary disease, c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding

Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01 Clinical Trial Optional)
Funding Opportunity PA-18-142 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases; including lower respiratory disease, chronic obstructive pulmonary disease, c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2017 Category: Research Source Type: funding

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
Funding Opportunity PA-18-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. This FOA calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and pro/prebiotic research including, but not limited to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2017 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
Notice NOT-NS-18-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 19, 2017 Category: Research Source Type: funding

Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening (R43)
Funding Opportunity RFA-ES-17-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43) and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop novel, physiologically-relevant in vitro screening systems (e.g., engineered 3-dimensional or organotypic models) using cells derived from animal species typically utilized for toxicological testing, which will replicate biological interactions and toxicological responses observed in animal tissues or organs, will produce assay data suitable for compari...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2017 Category: Research Source Type: funding

Notice of NIMH's Participation in PAR-17-438 "Assay development and screening for discovery of chemical probes or therapeutic agents (R01)"
Notice NOT-MH-17-041 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 8, 2017 Category: Research Source Type: funding

Notice of Correction in Expiration Date for PAR-17-438 "Assay development and screening for discovery of chemical probes or therapeutic agents (R01)"
Notice NOT-CA-17-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 2, 2017 Category: Research Source Type: funding

Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
Funding Opportunity PA-17-447 from the NIH Guide for Grants and Contracts. The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2017 Category: Research Source Type: funding

Compound Identification Development Cores (U2C)
Funding Opportunity RFA-RM-17-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish Compound Identification Development Cores (CIDC) to develop innovative approaches to enhance compound identification of the most significant, biomedically-relevant unknown metabolites. The ultimate goal of this FOA is to expand the repertoire of biologically relevant compounds that can be quickly and inexpensively identified in high throughput metabolomics experiments. An interdisciplinary approach and partnership among metabolomics experts, biomedical researchers, ch...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2017 Category: Research Source Type: funding

Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
The reproducibility and comparability of dietary supplement research is enhanced through rigorous analytical characterization of key experimental materials. The publication of analytical methods which have been thoroughly validated for specific, precise, accurate, and sensitive quantitative determination of chemical constituents of dietary supplements therefore makes critical contributions to the rigor and reproducibility of biomedical research. This FOA will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods. Th...
Source: NIDDK Funding Opportunities - August 1, 2017 Category: Endocrinology Source Type: funding

Dear Colleague Letter: Removal of Deadlines for the Combustion and Fire Systems Program in the Division of Chemical, Biological, Environmental, and Transport Systems in the Directorate for Engineering
Available Formats: HTML: https://www.nsf.gov/pubs/2017/nsf17117/nsf17117.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2017/nsf17117/nsf17117.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf17117Public Comment: Related Frequently Asked Questions (FAQs) NSF 17-118.This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 31, 2017 Category: Science Source Type: funding

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
Funding Opportunity PAR-17-438 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), NIH wishes to stimulate research in discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes; and to generate new insight into the biology of relevant diseases and processes that have yet to be validated as important drug targets. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 27, 2017 Category: Research Source Type: funding

Dear Colleague Letter: Removal of Deadlines for the Process Separations Program in the Division of Chemical, Biological, Environmental, and Transport Systems in the Directorate for Engineering
Available Formats: HTML: https://www.nsf.gov/pubs/2017/nsf17114/nsf17114.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2017/nsf17114/nsf17114.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf17114This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - July 24, 2017 Category: Science Source Type: funding